{"title":"附睾梗阻性无精子症输精管附睾吻合术治疗大鼠成功率的新方法。","authors":"Quanfa Tian, Jinjie Li, Xiaolong Fan, Liling Yao, Shanshan Xia, Zhihua Wu, Jingxiao Zhang, Yaoqiang Ren, Xiaofan Han, Xiaozhen Wang","doi":"10.21037/tau-2025-91","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Two-suture longitudinal intussusception vasoepididymostomy (LIVE) surgery has been confirmed by many studies in the treatment of epididymal obstruction; however, the success rate and anastomotic patency rate are not high, which cannot meet the modern human demand for a cure rate for this disease. Based on our preliminary research, we have reason to speculate that the new 2-suture circular intussusception vasoepididymostomy (CIVE) surgery group can greatly improve the anastomosis rate and success rate of treating epididymal obstruction patients. LIVE has become the preferred technique for epididymal and vas deferens anastomosis in North America, Europe, and globally for 22 years. Compared with LIVE, CIVE can greatly improve the anastomosis and success rate of treating epididymal obstruction patients. The aim of this study is to make CIVE the preferred technique for treating epididymal obstruction in North America, Europe, and globally. CIVE ultimately benefits more patients.</p><p><strong>Methods: </strong>Thirty-three male rats (type: Sprague-Dawley, SD) were randomly divided into control (group I) and experimental groups (groups II and III). After 3 weeks of epididymal obstruction, bilateral vasoepididymostomy was performed. In group II, the epididymal tubules (the epididymal tubules, which were cut into circular incisions) were punctured and lifted with a suture under a microscope, the vas deferens was incised obliquely at 45° for CIVE. In group III: LIVE was performed. After 3 months, patency was assessed in a blinded manner.</p><p><strong>Results: </strong>The rates of functional patency (presence of motile sperm in the vas deferens) were 90.9% and 63.6% in groups II and III, respectively (single-tailed test, P=0.042). On retrograde methylene blue vasography of the epididymis, the mechanical patency rate was similar to the functional patency rate. The incidence of sperm granulomas in postoperative groups II and III was 0% and 18.2%, respectively, with a single-tailed test P value of 0.24. Due to insufficient sample size, the sample size can be expanded for further verification in the later stage.</p><p><strong>Conclusions: </strong>Compared with LIVE, CIVE at a 45° oblique incision of the vas deferens provides a larger anastomotic area and has a higher recanalization rate, which is worthy of further investigation. The aim of this study is to propose a new surgical approach called 'CIVE'. By expanding the anastomotic area to reduce the risk of traditional surgical failure, the ultimate goal is to provide patients with safer and more efficient treatment options.</p>","PeriodicalId":23270,"journal":{"name":"Translational andrology and urology","volume":"14 7","pages":"1874-1881"},"PeriodicalIF":1.7000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12336738/pdf/","citationCount":"0","resultStr":"{\"title\":\"A new surgical method of vasoepididymostomy for epididymal obstructive azoospermia to improve the success rate in the rat.\",\"authors\":\"Quanfa Tian, Jinjie Li, Xiaolong Fan, Liling Yao, Shanshan Xia, Zhihua Wu, Jingxiao Zhang, Yaoqiang Ren, Xiaofan Han, Xiaozhen Wang\",\"doi\":\"10.21037/tau-2025-91\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Two-suture longitudinal intussusception vasoepididymostomy (LIVE) surgery has been confirmed by many studies in the treatment of epididymal obstruction; however, the success rate and anastomotic patency rate are not high, which cannot meet the modern human demand for a cure rate for this disease. Based on our preliminary research, we have reason to speculate that the new 2-suture circular intussusception vasoepididymostomy (CIVE) surgery group can greatly improve the anastomosis rate and success rate of treating epididymal obstruction patients. LIVE has become the preferred technique for epididymal and vas deferens anastomosis in North America, Europe, and globally for 22 years. Compared with LIVE, CIVE can greatly improve the anastomosis and success rate of treating epididymal obstruction patients. The aim of this study is to make CIVE the preferred technique for treating epididymal obstruction in North America, Europe, and globally. CIVE ultimately benefits more patients.</p><p><strong>Methods: </strong>Thirty-three male rats (type: Sprague-Dawley, SD) were randomly divided into control (group I) and experimental groups (groups II and III). After 3 weeks of epididymal obstruction, bilateral vasoepididymostomy was performed. In group II, the epididymal tubules (the epididymal tubules, which were cut into circular incisions) were punctured and lifted with a suture under a microscope, the vas deferens was incised obliquely at 45° for CIVE. In group III: LIVE was performed. After 3 months, patency was assessed in a blinded manner.</p><p><strong>Results: </strong>The rates of functional patency (presence of motile sperm in the vas deferens) were 90.9% and 63.6% in groups II and III, respectively (single-tailed test, P=0.042). On retrograde methylene blue vasography of the epididymis, the mechanical patency rate was similar to the functional patency rate. The incidence of sperm granulomas in postoperative groups II and III was 0% and 18.2%, respectively, with a single-tailed test P value of 0.24. Due to insufficient sample size, the sample size can be expanded for further verification in the later stage.</p><p><strong>Conclusions: </strong>Compared with LIVE, CIVE at a 45° oblique incision of the vas deferens provides a larger anastomotic area and has a higher recanalization rate, which is worthy of further investigation. The aim of this study is to propose a new surgical approach called 'CIVE'. By expanding the anastomotic area to reduce the risk of traditional surgical failure, the ultimate goal is to provide patients with safer and more efficient treatment options.</p>\",\"PeriodicalId\":23270,\"journal\":{\"name\":\"Translational andrology and urology\",\"volume\":\"14 7\",\"pages\":\"1874-1881\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12336738/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational andrology and urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21037/tau-2025-91\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ANDROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational andrology and urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tau-2025-91","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ANDROLOGY","Score":null,"Total":0}
A new surgical method of vasoepididymostomy for epididymal obstructive azoospermia to improve the success rate in the rat.
Background: Two-suture longitudinal intussusception vasoepididymostomy (LIVE) surgery has been confirmed by many studies in the treatment of epididymal obstruction; however, the success rate and anastomotic patency rate are not high, which cannot meet the modern human demand for a cure rate for this disease. Based on our preliminary research, we have reason to speculate that the new 2-suture circular intussusception vasoepididymostomy (CIVE) surgery group can greatly improve the anastomosis rate and success rate of treating epididymal obstruction patients. LIVE has become the preferred technique for epididymal and vas deferens anastomosis in North America, Europe, and globally for 22 years. Compared with LIVE, CIVE can greatly improve the anastomosis and success rate of treating epididymal obstruction patients. The aim of this study is to make CIVE the preferred technique for treating epididymal obstruction in North America, Europe, and globally. CIVE ultimately benefits more patients.
Methods: Thirty-three male rats (type: Sprague-Dawley, SD) were randomly divided into control (group I) and experimental groups (groups II and III). After 3 weeks of epididymal obstruction, bilateral vasoepididymostomy was performed. In group II, the epididymal tubules (the epididymal tubules, which were cut into circular incisions) were punctured and lifted with a suture under a microscope, the vas deferens was incised obliquely at 45° for CIVE. In group III: LIVE was performed. After 3 months, patency was assessed in a blinded manner.
Results: The rates of functional patency (presence of motile sperm in the vas deferens) were 90.9% and 63.6% in groups II and III, respectively (single-tailed test, P=0.042). On retrograde methylene blue vasography of the epididymis, the mechanical patency rate was similar to the functional patency rate. The incidence of sperm granulomas in postoperative groups II and III was 0% and 18.2%, respectively, with a single-tailed test P value of 0.24. Due to insufficient sample size, the sample size can be expanded for further verification in the later stage.
Conclusions: Compared with LIVE, CIVE at a 45° oblique incision of the vas deferens provides a larger anastomotic area and has a higher recanalization rate, which is worthy of further investigation. The aim of this study is to propose a new surgical approach called 'CIVE'. By expanding the anastomotic area to reduce the risk of traditional surgical failure, the ultimate goal is to provide patients with safer and more efficient treatment options.
期刊介绍:
ranslational Andrology and Urology (Print ISSN 2223-4683; Online ISSN 2223-4691; Transl Androl Urol; TAU) is an open access, peer-reviewed, bi-monthly journal (quarterly published from Mar.2012 - Dec. 2014). The main focus of the journal is to describe new findings in the field of translational research of Andrology and Urology, provides current and practical information on basic research and clinical investigations of Andrology and Urology. Specific areas of interest include, but not limited to, molecular study, pathology, biology and technical advances related to andrology and urology. Topics cover range from evaluation, prevention, diagnosis, therapy, prognosis, rehabilitation and future challenges to urology and andrology. Contributions pertinent to urology and andrology are also included from related fields such as public health, basic sciences, education, sociology, and nursing.